Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylanta CalciTabs Antacid/Calcium Supplement Benefits Featured In TV Ad

This article was originally published in The Tan Sheet

Executive Summary

Mylanta CalciTabs antacid/calcium supplements provide "100% of your daily calcium requirement plus all the heartburn relief of Mylanta," J&J/Merck says in a TV commercial that broke the week of Feb. 13.

You may also be interested in...



OTC/Supplement Combo New Safety/Efficacy Data Not Needed - Attorney Hutt

OTC/supplement combination products do not require premarket clinical trials to establish safety and efficacy if data exist on the individual ingredients, attorney Peter Barton Hutt of Covington & Burling (Washington, D.C.) asserted at the Consumer Healthcare Products Association Legal & Regulatory Conference in D.C. Nov. 30.

OTC/Supplement Combo New Safety/Efficacy Data Not Needed - Attorney Hutt

OTC/supplement combination products do not require premarket clinical trials to establish safety and efficacy if data exist on the individual ingredients, attorney Peter Barton Hutt of Covington & Burling (Washington, D.C.) asserted at the Consumer Healthcare Products Association Legal & Regulatory Conference in D.C. Nov. 30.

OTC/Supplement Combo New Safety/Efficacy Data Not Needed - Attorney Hutt

OTC/supplement combination products do not require premarket clinical trials to establish safety and efficacy if data exist on the individual ingredients, attorney Peter Barton Hutt of Covington & Burling (Washington, D.C.) asserted at the Consumer Healthcare Products Association Legal & Regulatory Conference in D.C. Nov. 30.

Topics

UsernamePublicRestriction

Register

LL1135415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel